These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30110685)

  • 1. A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.
    Trivedi MH; South C; Jha MK; Rush AJ; Cao J; Kurian B; Phillips M; Pizzagalli DA; Trombello JM; Oquendo MA; Cooper C; Dillon DG; Webb C; Grannemann BD; Bruder G; McGrath PJ; Parsey R; Weissman M; Fava M
    Psychother Psychosom; 2018; 87(5):285-295. PubMed ID: 30110685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
    Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
    J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
    Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
    JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial.
    Whitton AE; Webb CA; Dillon DG; Kayser J; Rutherford A; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH; Pizzagalli DA
    Biol Psychiatry; 2019 May; 85(10):872-880. PubMed ID: 30718038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data.
    Shinohara K; Tanaka S; Imai H; Noma H; Maruo K; Cipriani A; Yamawaki S; Furukawa TA
    Evid Based Ment Health; 2019 Feb; 22(1):10-16. PubMed ID: 30665989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Poirot MG; Ruhe HG; Mutsaerts HMM; Maximov II; Groote IR; Bjørnerud A; Marquering HA; Reneman L; Caan MWA
    Am J Psychiatry; 2024 Mar; 181(3):223-233. PubMed ID: 38321916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
    Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
    Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized fMRI connectivity defines signatures of antidepressant and placebo responses in major depression.
    Zhao K; Xie H; Fonzo GA; Tong X; Carlisle N; Chidharom M; Etkin A; Zhang Y
    Mol Psychiatry; 2023 Jun; 28(6):2490-2499. PubMed ID: 36732585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR; Guo H; Németh G; Harsányi J; Thase ME
    Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life: Findings From the EMBARC and STRIDE Studies and the VitalSign6 Project.
    Jha MK; Schatzberg A; Minhajuddin A; Chin Fatt C; Mayes TL; Trivedi MH
    J Clin Psychiatry; 2021 Apr; 82(3):. PubMed ID: 34000130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
    Chin Fatt CR; Jha MK; Cooper CM; Fonzo G; South C; Grannemann B; Carmody T; Greer TL; Kurian B; Fava M; McGrath PJ; Adams P; McInnis M; Parsey RV; Weissman M; Phillips ML; Etkin A; Trivedi MH
    Am J Psychiatry; 2020 Feb; 177(2):143-154. PubMed ID: 31537090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
    Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
    JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early score fluctuation and placebo response in a study of major depressive disorder.
    Targum SD; Cameron BR; Ferreira L; MacDonald ID
    J Psychiatr Res; 2020 Feb; 121():118-125. PubMed ID: 31812110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.
    Webb CA; Trivedi MH; Cohen ZD; Dillon DG; Fournier JC; Goer F; Fava M; McGrath PJ; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Huys Q; Bruder G; Kurian BT; Jha M; DeRubeis RJ; Pizzagalli DA
    Psychol Med; 2019 May; 49(7):1118-1127. PubMed ID: 29962359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS).
    Nakonezny PA; Mayes TL; Byerly MJ; Emslie GJ
    J Psychiatr Res; 2015 Sep; 68():346-53. PubMed ID: 26028546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
    Korb AS; Hunter AM; Cook IA; Leuchter AF
    Clin Neurophysiol; 2009 Jul; 120(7):1313-9. PubMed ID: 19539524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials.
    Jha MK; South C; Trivedi J; Minhajuddin A; Rush AJ; Trivedi MH
    Int J Neuropsychopharmacol; 2019 May; 22(5):339-348. PubMed ID: 30958879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials.
    Zilcha-Mano S; Wang Z; Peterson BS; Wall MM; Chen Y; Wager TD; Brown PJ; Roose SP; Rutherford BR
    J Psychiatr Res; 2019 Sep; 116():19-25. PubMed ID: 31176108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
    Inoue T; Sasai K; Kitagawa T; Nishimura A; Inada I
    Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.